The Board of Directors of Bauhaus International (Holdings) Limited announced that Dr. Wong Yui Lam ("Dr. Wong") has informed the Company of his retirement and has tendered his resignation as an executive Director with effect from 26 June 2023 to devote more time to his personal endeavors. Dr. Wong has confirmed that he has no disagreement with the Board and is not aware of any matters in relation to his resignation as the executive Director that needs to be brought to the attention of the shareholders of the Company (the "Shareholders"). The Board announced that Ms. Choi Sze Man, Mandy ("Ms. Choi") has been appointed as an independent non-executive Director, the chairman of the remuneration committee of the Company (the "Remuneration Committee"), and a member of each of the audit committee of the Company (the "Audit Committee") and the nomination committee of the Company (the "Nomination Committee") (collectively, the "Appointment"). Ms. Choi, aged 39, graduated from the University of Sydney in 2005 with a Bachelor's degree in Economic & Social Sciences. Ms. Choi was also awarded an Executive Diploma in Corporate Governance and Innovation Leadership by the Hong Kong Institute of Directors ("HKIoD") in association with IVEY Business School at the University of Western Ontario in 2021 and currently is a fellow member of HKIoD. Ms. Choi has more than 9 years of experience in business operation, business management and strategies planning. She is a director of a seafood trading company based in Hong Kong and is responsible for cost
management, factory and product quality control, business-to-business client relations and logistic control. Following the Appointment, the composition of the Board committees has changed with effect from 26 June 2023 as follows: Mr. Mak Wing Kit has stepped down as the chairman of the Remuneration Committee, and has been redesignated as a member of the Remuneration Committee; and Ms. Choi has been appointed as the chairman of the Remuneration Committee, and a member of each of the Audit Committee and the Nomination Committee. The Board of the Company announces that Dr. Wong ceased to act as an authorized representative of the Company and Mr. Yeung Yat Hang has been appointed as an authorized representative of the Company as required under Rule 3.05 of the Listing Rules with effect from 26 June 2023.